Public health concerns of substandard antidiabetic medicine: Quality estimation of pioglitazone by a cross-sectional survey

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-D-020-Monday
• By: RAHMAN, Mohammad Sofiqur (Kanazawa University, Japan, Drug Management & Policy, Kanazawa, Japan)
• Co-author(s): Mohammad Sofiqur Rahman: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
  Erina Maeda: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
  Su Chang: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
  Naoko Yoshida: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
  Hirohito Tsuboi: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
  Kazuko Kimura: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
  
• Abstract:

  Backgrounds

  Poor quality medicines both falsified and substandard have serious implications to public health. 

  Aims

  The objective of this study was to explore the quality of pioglitazone, a drug used in the treatment of Type 2 diabetes in China, Myanmar and through purchases from internet sources.

  Methods

  Using cross-sectional sampling, samples (N =

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login